bluebird bio, Inc.
BLUE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$240,715 | -$211,913 | -$266,578 | -$819,378 |
| Dep. & Amort. | $61,244 | $28,525 | $5,001 | $19,649 |
| Deferred Tax | $0 | $0 | $0 | $568 |
| Stock-Based Comp. | $13,737 | $19,429 | $35,188 | $127,915 |
| Change in WC | -$130,045 | -$49,721 | -$39,122 | $17,985 |
| Other Non-Cash | $35,759 | -$21,366 | -$87,442 | $17,622 |
| Operating Cash Flow | -$260,020 | -$235,046 | -$352,953 | -$635,639 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,599 | -$4,189 | -$13,208 | -$23,003 |
| Net Acquisitions | $0 | $0 | $0 | $8,500 |
| Inv. Purchases | $0 | -$43,297 | $0 | -$451,391 |
| Inv. Sales/Matur. | $0 | $114,374 | $161,661 | $926,651 |
| Other Inv. Act. | $6,496 | $88,062 | $102,000 | $101,800 |
| Investing Cash Flow | $3,897 | $154,950 | $250,453 | $562,557 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$14,634 | -$54,367 | -$36,734 | $0 |
| Stock Issued | $0 | $248,198 | $54,237 | $74,975 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $102,103 | $2,417 | $16 | -$168,929 |
| Financing Cash Flow | $87,469 | $196,248 | $17,519 | -$93,954 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$168,654 | $116,152 | -$48,247 | -$167,036 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $274,597 | $158,445 | $206,692 | $373,728 |
| End Cash | $105,943 | $274,597 | $158,445 | $206,692 |
| Free Cash Flow | -$262,619 | -$244,103 | -$366,161 | -$658,642 |